Gemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: an intergroup trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples